These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17883305)

  • 21. [Right hepatectomy on a cirrhotic liver].
    Diáz de Liaño Argüelles A; Merck B; Ochoa L
    Ann Chir; 1992; 46(10):953-4. PubMed ID: 1338679
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary malignant tumors of the liver].
    Astrukov E; Baev S
    Khirurgiia (Sofiia); 1991; 44(1):64-73. PubMed ID: 1658427
    [No Abstract]   [Full Text] [Related]  

  • 23. [Development of hepatocellular carcinoma from chronic hepatitis C].
    Yoshida H
    Nihon Rinsho; 2011 May; 69 Suppl 4():309-13. PubMed ID: 22096936
    [No Abstract]   [Full Text] [Related]  

  • 24. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma developed in a patient with chronic hepatitis C after the disappearance of hepatitis C virus due to interferon therapy.
    Inoue M; Ohhira M; Ohtake T; Matsumoto A; Kawashima T; Fujimoto Y; Hasebe C; Ono M; Kohgo Y
    Hepatogastroenterology; 1999; 46(28):2554-60. PubMed ID: 10522040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [From viral hepatitis to hepatocellular carcinoma].
    Okita K
    Nihon Naika Gakkai Zasshi; 2001 Mar; 90(3):452-6. PubMed ID: 11307535
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocellular carcinoma: comparison of two different periods at the same center.
    Soresi M; La Spada E; Giannitrapani L; Campagna E; Di Gesaro V; Granà W; Sandonato L; Brancatelli G; Rotolo G; Affronti A; Messina S; Montalto G
    Eur J Intern Med; 2010 Apr; 21(2):127-30. PubMed ID: 20206885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome-associated hepatocellular carcinoma: Questions still unanswered.
    Pawlik TM; Soubrane O
    J Hepatol; 2015 Jul; 63(1):8-9. PubMed ID: 25862602
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-cirrhotic hepatocellular carcinoma in a young active duty male.
    Thomas DB; Hall AB; Michel M
    Mil Med; 2011 Apr; 176(4):475-6. PubMed ID: 21539174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: flaws in the cure, or a clue to the flaws?
    Farrell GC
    J Gastroenterol Hepatol; 1999 Sep; 14(9):833-7. PubMed ID: 10535462
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
    Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
    Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance for hepatocellular carcinoma secondary to cardiogenic cirrhosis in patients with congenital heart disease.
    Augustyn A; Peng L; Singal AG; Yopp AC
    Clin Res Cardiol; 2015 May; 104(5):446-9. PubMed ID: 25875944
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver cancer and alcohol.
    Grewal P; Viswanathen VA
    Clin Liver Dis; 2012 Nov; 16(4):839-50. PubMed ID: 23101985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
    Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
    Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case records of the Massachusetts General Hospital. Case 38-2008. A 58-year-old man with hemophilia, hepatocellular carcinoma, and intractable bleeding.
    Dzik WH; Laposata M; Hertl M; Sandberg WS; Chatterji M; Misdraji J
    N Engl J Med; 2008 Dec; 359(24):2587-97. PubMed ID: 19073979
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
    Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
    EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fibrolamellar hepatocellular carcinoma in a patient with chronic viral B hepatitis].
    Da Ines D; Lannareix V; Petitcolin V; Bailly A; Charpy C; Abergel A; Chipponi J; Garcier JM
    Gastroenterol Clin Biol; 2009 May; 33(5):382-6. PubMed ID: 19361940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C.
    González-Peralta RP; Langham MR; Andres JM; Mohan P; Colombani PM; Alford MK; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):630-5. PubMed ID: 19412012
    [No Abstract]   [Full Text] [Related]  

  • 39. Regional differences in hepatocellular carcinoma and its surgical treatment.
    Ezaki T; Stansby GP; Hobbs KE
    HPB Surg; 1991 Jun; 4(2):121-8. PubMed ID: 1657117
    [No Abstract]   [Full Text] [Related]  

  • 40. Synchronous presentation of tuberculosis and hepatocellular carcinoma in a cirrhotic patient: a case report.
    Shah D; P G; S S; Koushik AK
    Trop Doct; 2020 Jan; 50(1):71-74. PubMed ID: 31530106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.